Used primarily in the management of type 2 diabetes mellitus, this compound acts as a rapid-acting insulin secretagogue that stimulates insulin release from pancreatic beta cells in response to meals. It helps control postprandial blood glucose levels by enhancing glucose-dependent insulin secretion, making it effective for patients with residual beta-cell function. Due to its quick onset and short duration of action, it is typically taken shortly before meals to reduce the risk of hypoglycemia between meals. It is often prescribed as monotherapy or in combination with other antidiabetic agents like metformin for improved glycemic control.